The Role of NK1.1<sup>+</sup> Cells in the Protection against MHC Class I<sup>+</sup> HPV16-Associated Tumours Cited by

Fol. Biol. 2004, 50, 200-202

https://doi.org/10.14712/fb2004050060200

Jana Šímová, J. Bubeník, J. Bieblová, T. Jandlová

Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Prague, Czech Republic

Received November 2004
Accepted November 2004

\u0160ímová J, Polláková V, Indrová M, Miky\u0161ková R, Bieblová J, \u0160t\u011bpánek I, Bubeník J, Reini\u0161 M: Immunotherapy augments the effect of 5-azacytidine on HPV16-associated tumours with different MHC class I-expression status. Br J Cancer 2011, 105, 1533. <https://doi.org/10.1038/bjc.2011.428>
Reini\u0161 Milan: Immunotherapy of MHC Class I-Deficient Tumors. Future Oncol. 2010, 6, 1577. <https://doi.org/10.2217/fon.10.128>